Yahoo Web Search

Search results

1. yulab.hms.harvard.edu › yuKun-Hsing Yu, MD, PhD | The Yu Lab

   yulab.hms.harvard.edu › yu

   • Cached

   Kun-Hsing "Kun" Yu, M.D, Ph.D. is an Assistant Professor in the Department of Biomedical Informatics at Harvard Medical School. He developed the first fully automated artificial intelligence (AI) algorithm to extract thousands of features from whole-slide histopathology images, discovered the molecular mechanisms underpinning the microscopic ...

   • Talks

     Featuring Yu et al. Nature Communications. 2016 Aug...

   • Course

     Semester: Spring 2. Deep learning is a subfield of machine...

   • Publications

     Kun-Hsing Yu, Andrew L. Beam, Isaac S. Kohane. Nature...

   • Research

     Enhancing Clinical Practice with Real-World Data. We develop...

   • People

     Alumni: Christopher Jackson, MD, MEng. Current: Assistant...

   • Open Positions

     The Department of Biomedical Informatics (DBMI) at Harvard...

2. Images

   • 
   • 
   • 
   • 

   View all

3. www.hsph.harvard.edu › profile › kun-hsing-yuKun-Hsing Yu - Harvard T.H. Chan School of Public Health

   www.hsph.harvard.edu › profile › kun-hsing-yu

   • Cached

   Kun-Hsing "Kun" Yu received his PhD in Biomedical Informatics and PhD Minor in Computer Science from Stanford University, and he obtained his MD from National Taiwan University, Taiwan. His research focuses on the integration of quantitative histopathology image patterns with multi-omics (genomics, epigenomics, transcriptomics, and proteomics ...

4. yulab.hms.harvard.edu › publications_allPublications | The Yu Lab

   yulab.hms.harvard.edu › publications_all

   • Cached

   Machine learning for cryosection pathology predicts the 2021 WHO classification of glioma. MacLean P. Nasrallah*, Junhan Zhao*, Cheng Che Tsai*, David Meredith, Eliana Marostica, Keith L. Ligon, Jeffrey A. Golden, Kun-Hsing Yu. Med. 2023 Aug 11;4 (8):526-540.e4. [Pubmed] [Codes]

   • Author: Kun-Hsing Yu

5. www.ncbi.nlm.nih.gov › pmc › articlesSodium-Glucose Cotransport Protein 2 Inhibitors in Patients ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Jan 3, 2024 · Importance. Sodium-glucose cotransport protein 2 inhibitors (SGLT-2is) have demonstrated associations with positive kidney-related and cardiovascular outcomes in patients with type 2 diabetes. However, the association of SGLT-2is with outcomes among patients with type 2 diabetes and acute kidney disease (AKD) remains unclear. Objective.

   • DOI: 10.1001/jamanetworkopen.2023.50050
   • Published: 2024/01

   • Publication: JAMA Netw Open. 2024 Jan; 7(1): e2350050.

6. scholar.google.com › citations‪Kun-Hsing Yu‬ - ‪Google Scholar‬

   scholar.google.com › citations

   • Cached

   Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks. KH Yu, F Wang, GJ Berry, C Re, RB Altman, M Snyder, IS Kohane. Journal of the American Medical Informatics Association 27 (5), 757-769. , 2020.

7. scholar.harvard.edu › khyu › publicationsPublications | Kun-Hsing Yu, MD, PhD - Scholars at Harvard

   scholar.harvard.edu › khyu › publications

   • Cached

   Kun-Hsing Yu, MD, PhD Assistant Professor, Department of Biomedical Informatics. 10 Shattuck Street, Fourth Floor Boston, MA 02115

8. scholar.google.com › citations‪Hsing-Yu Chen‬ - ‪Google Scholar‬

   scholar.google.com › citations

   • Cached

   ‪Associate professor, Chang Gung Memorial Hospital‬ - ‪‪Cited by 969‬‬ - ‪Traditional Chinese medicine‬ - ‪Epidemiology‬ - ‪Big data‬ - ‪pharmacology network‬